| Year |
Citation |
Score |
| 2024 |
Proteau-Lemieux M, Knoth IS, Davoudi S, Martin CO, Bélanger AM, Fontaine V, Côté V, Agbogba K, Vachon K, Whitlock K, Biag HMB, Thurman AJ, Rosenfelt C, Tassone F, Frei J, ... ... Schneider A, et al. Specific EEG resting state biomarkers in FXS and ASD. Journal of Neurodevelopmental Disorders. 16: 53. PMID 39251926 DOI: 10.1186/s11689-024-09570-9 |
0.316 |
|
| 2024 |
Chi MH, Bourgeois JA, Santos E, Kim K, Ponzini MD, Mendoza G, Schneider A, Hessl D, Tassone F, Hagerman RJ. Psychiatric Manifestations in Early to Middle Stages of Fragile X-Associated Tremor-Ataxia Syndrome (FXTAS). The Journal of Neuropsychiatry and Clinical Neurosciences. appineuropsych202302. PMID 39113493 DOI: 10.1176/appi.neuropsych.20230215 |
0.703 |
|
| 2024 |
Seng P, Montanaro FAM, Biag HMB, Salcedo-Arellano MJ, Kim K, Ponzini MD, Tassone F, Schneider A, Abbeduto L, Thurman AJ, Hessl D, Bolduc FV, Jacquemont S, Lippé S, Hagerman RJ. Longitudinal follow-up of metformin treatment in Fragile X Syndrome. Frontiers in Psychology. 15: 1305597. PMID 38939222 DOI: 10.3389/fpsyg.2024.1305597 |
0.715 |
|
| 2024 |
Tak Y, Schneider A, Santos E, Randol JL, Tassone F, Hagerman P, Hagerman RJ. Unmethylated Mosaic Full Mutation Males without Fragile X Syndrome. Genes. 15. PMID 38540390 DOI: 10.3390/genes15030331 |
0.566 |
|
| 2024 |
Jiraanont P, Zafarullah M, Sulaiman N, Espinal GM, Randol JL, Durbin-Johnson B, Schneider A, Hagerman RJ, Hagerman PJ, Tassone F. FMR1 Protein Expression Correlates with Intelligence Quotient in Both Peripheral Blood Mononuclear Cells and Fibroblasts from Individuals with an FMR1 Mutation. The Journal of Molecular Diagnostics : Jmd. PMID 38522837 DOI: 10.1016/j.jmoldx.2024.02.007 |
0.532 |
|
| 2023 |
Santos E, Clark C, Biag HMB, Tang SJ, Kim K, Ponzini MD, Schneider A, Giulivi C, Montanaro FAM, Gipe JT, Dayton J, Randol JL, Yao PJ, Manolopoulos A, Kapogiannis D, et al. Open-Label Sulforaphane Trial in FMR1 Premutation Carriers with Fragile-X-Associated Tremor and Ataxia Syndrome (FXTAS). Cells. 12. PMID 38132093 DOI: 10.3390/cells12242773 |
0.566 |
|
| 2023 |
Hessl D, Mandujano Rojas K, Ferrer E, Espinal G, Famula J, Schneider A, Hagerman R, Tassone F, Rivera SM. FMR1 Carriers Report Executive Function Changes Prior to Fragile X-Associated Tremor/Ataxia Syndrome: A Longitudinal Study. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 38124331 DOI: 10.1002/mds.29695 |
0.771 |
|
| 2023 |
Aishworiya R, Tak YE, Ponzini MD, Biag HMB, Salcedo-Arellano MJ, Kim K, Tassone F, Schneider A, Thurman AJ, Abbeduto L, Hessl D, Randol JL, Bolduc FV, Lippe S, Hagerman P, et al. Adaptive, behavioral, and cognitive outcomes in individuals with fragile X syndrome with varying autism severity. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. PMID 37724826 DOI: 10.1002/jdn.10299 |
0.693 |
|
| 2023 |
Hessl D, Rojas KM, Ferrer E, Espinal G, Famula J, Schneider A, Hagerman R, Tassone F, Rivera SM. A Longitudinal Study of Executive Function in Daily Life in Male Fragile X Premutation Carriers and Association with FXTAS Conversion. Medrxiv : the Preprint Server For Health Sciences. PMID 37693384 DOI: 10.1101/2023.08.31.23294855 |
0.737 |
|
| 2023 |
Aishworiya R, Biag HMB, Salcedo-Arellano MJ, Musa Z, Schneider A, Clark C, Santos E, Tassone F, Hagerman R. Fragile X Syndrome and Fetal Alcohol Syndrome: Occurrence of Dual Diagnosis in a Set of Triplets. Journal of Developmental and Behavioral Pediatrics : Jdbp. PMID 37556593 DOI: 10.1097/DBP.0000000000001204 |
0.531 |
|
| 2023 |
Aishworiya R, Chi MH, Zafarullah M, Mendoza G, Ponzini MD, Kim K, Biag HMB, Thurman AJ, Abbeduto L, Hessl D, Randol JL, Bolduc FV, Jacquemont S, Lippé S, Hagerman P, ... ... Schneider A, et al. Intercorrelation of Molecular Biomarkers and Clinical Phenotype Measures in Fragile X Syndrome. Cells. 12. PMID 37508583 DOI: 10.3390/cells12141920 |
0.667 |
|
| 2022 |
Aishworiya R, Protic D, Tang SJ, Schneider A, Tassone F, Hagerman R. Fragile X-Associated Neuropsychiatric Disorders (FXAND) in Young Fragile X Premutation Carriers. Genes. 13. PMID 36553666 DOI: 10.3390/genes13122399 |
0.587 |
|
| 2022 |
Tang SJ, Giri S, Pahlavan N, Han SH, Santos ER, Espinal G, Aishworiya R, Schneider A, Hessl D, Rivera SM, Hagerman RJ. Tophaceous gout of the nose in a male premutation carrier. Clinical Case Reports. 10: e6586. PMID 36447664 DOI: 10.1002/ccr3.6586 |
0.762 |
|
| 2022 |
Famula J, Ferrer E, Hagerman RJ, Tassone F, Schneider A, Rivera SM, Hessl D. Neuropsychological changes in FMR1 premutation carriers and onset of fragile X-associated tremor/ataxia syndrome. Journal of Neurodevelopmental Disorders. 14: 23. PMID 35321639 DOI: 10.1186/s11689-022-09436-y |
0.769 |
|
| 2022 |
Proteau-Lemieux M, Knoth IS, Agbogba K, Côté V, Barlahan Biag HM, Thurman AJ, Martin CO, Bélanger AM, Rosenfelt C, Tassone F, Abbeduto LJ, Jacquemont S, Hagerman R, Bolduc F, Hessl D, ... Schneider A, et al. Corrigendum: EEG Signal Complexity Is Reduced During Resting-State in Fragile X Syndrome. Frontiers in Psychiatry. 13: 867000. PMID 35280176 DOI: 10.3389/fpsyt.2022.867000 |
0.653 |
|
| 2022 |
Johnson D, Santos E, Kim K, Ponzini MD, McLennan YA, Schneider A, Tassone F, Hagerman RJ. Increased Pain Symptomatology Among Females vs. Males With Fragile X-Associated Tremor/Ataxia Syndrome. Frontiers in Psychiatry. 12: 762915. PMID 35126193 DOI: 10.3389/fpsyt.2021.762915 |
0.408 |
|
| 2021 |
Proteau-Lemieux M, Knoth IS, Agbogba K, Côté V, Barlahan Biag HM, Thurman AJ, Martin CO, Bélanger AM, Rosenfelt C, Tassone F, Abbeduto LJ, Jacquemont S, Hagerman R, Bolduc F, Hessl D, ... Schneider A, et al. EEG Signal Complexity Is Reduced During Resting-State in Fragile X Syndrome. Frontiers in Psychiatry. 12: 716707. PMID 34858220 DOI: 10.3389/fpsyt.2021.716707 |
0.65 |
|
| 2021 |
Salcedo-Arellano MJ, Sanchez D, Wang JY, McLennan YA, Clark CJ, Juarez P, Schneider A, Tassone F, Hagerman RJ, Martínez-Cerdeño V. Case Report: Coexistence of Alzheimer-Type Neuropathology in Fragile X-Associated Tremor Ataxia Syndrome. Frontiers in Neuroscience. 15: 720253. PMID 34602969 DOI: 10.3389/fnins.2021.720253 |
0.527 |
|
| 2020 |
Hessl D, Libero L, Schneider A, Kerns C, Winder-Patel B, Heath B, Lee J, Coleman C, Sharma N, Solomon M, Nordahl CW, Amaral DG. Fear Potentiated Startle in Children With Autism Spectrum Disorder: Association With Anxiety Symptoms and Amygdala Volume. Autism Research : Official Journal of the International Society For Autism Research. PMID 33372389 DOI: 10.1002/aur.2460 |
0.571 |
|
| 2020 |
Napoli E, McLennan YA, Schneider A, Tassone F, Hagerman RJ, Giulivi C. Characterization of the Metabolic, Clinical and Neuropsychological Phenotype of Female Carriers of the Premutation in the X-Linked Gene. Frontiers in Molecular Biosciences. 7: 578640. PMID 33195422 DOI: 10.3389/fmolb.2020.578640 |
0.534 |
|
| 2020 |
Rajaratnam A, Potter LA, Biag HMB, Schneider A, Petrasic IC, Hagerman RJ. Review of Autism Profiles and Response to Sertraline in Fragile X Syndrome-Associated Autism vs. Non-syndromic Autism; Next Steps for Targeted Treatment. Frontiers in Neurology. 11: 581429. PMID 33193037 DOI: 10.3389/fneur.2020.581429 |
0.549 |
|
| 2020 |
Schneider A, Summers S, Tassone F, Seritan A, Hessl D, Hagerman P, Hagerman R. Women with Fragile X-associated Tremor/Ataxia Syndrome. Movement Disorders Clinical Practice. 7: 910-919. PMID 33163562 DOI: 10.1002/Mdc3.13084 |
0.742 |
|
| 2020 |
Schneider A, Winarni TI, Cabal-Herrera AM, Bacalman S, Gane L, Hagerman P, Tassone F, Hagerman R. Elevated FMR1-mRNA and lowered FMRP - A double-hit mechanism for psychiatric features in men with FMR1 premutations. Translational Psychiatry. 10: 205. PMID 32576818 DOI: 10.1038/S41398-020-00863-W |
0.615 |
|
| 2020 |
Aydin EY, Schneider A, Protic D, Wang JY, Martínez-Cerdeño V, Tassone F, Tang HT, Perlman S, Hagerman RJ. Rapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer's Disease. Clinical Interventions in Aging. 15: 285-292. PMID 32161452 DOI: 10.2147/Cia.S240314 |
0.6 |
|
| 2020 |
Santos E, Emeka-Nwonovo C, Wang JY, Schneider A, Tassone F, Hagerman P, Hagerman R. Developmental aspects of FXAND in a man with the FMR1 premutation. Molecular Genetics & Genomic Medicine. e1050. PMID 31899609 DOI: 10.1002/Mgg3.1050 |
0.599 |
|
| 2019 |
Kim K, Hessl D, Randol JL, Espinal GM, Schneider A, Protic D, Aydin EY, Hagerman RJ, Hagerman PJ. Association between IQ and FMR1 protein (FMRP) across the spectrum of CGG repeat expansions. Plos One. 14: e0226811. PMID 31891607 DOI: 10.1371/Journal.Pone.0226811 |
0.725 |
|
| 2019 |
Potter LA, Scholze DA, Biag HMB, Schneider A, Chen Y, Nguyen DV, Rajaratnam A, Rivera SM, Dwyer PS, Tassone F, Al Olaby RR, Choudhary NS, Salcedo-Arellano MJ, Hagerman RJ. A Randomized Controlled Trial of Sertraline in Young Children With Autism Spectrum Disorder. Frontiers in Psychiatry. 10: 810. PMID 31780970 DOI: 10.3389/Fpsyt.2019.00810 |
0.686 |
|
| 2019 |
Biag HMB, Potter LA, Wilkins V, Afzal S, Rosvall A, Salcedo-Arellano MJ, Rajaratnam A, Manzano-Nunez R, Schneider A, Tassone F, Rivera SM, Hagerman RJ. Metformin treatment in young children with fragile X syndrome. Molecular Genetics & Genomic Medicine. e956. PMID 31520524 DOI: 10.1002/Mgg3.956 |
0.706 |
|
| 2019 |
Protic D, Aydin EY, Tassone F, Tan MM, Hagerman RJ, Schneider A. Cognitive and behavioral improvement in adults with fragile X syndrome treated with metformin-two cases. Molecular Genetics & Genomic Medicine. e745. PMID 31104364 DOI: 10.1002/Mgg3.745 |
0.601 |
|
| 2018 |
El-Deeb M, Adams P, Schneider A, Salcedo-Arellano MJ, Tassone F, Hagerman R. Fentanyl overdose in a female with the premutation and FXTAS. Journal of Molecular Genetics (Isleworth, London, England). 1. PMID 31032490 DOI: 10.31038/JMG.1000101 |
0.565 |
|
| 2018 |
Hagerman RJ, Protic D, Rajaratnam A, Salcedo-Arellano MJ, Aydin EY, Schneider A. Fragile X-Associated Neuropsychiatric Disorders (FXAND). Frontiers in Psychiatry. 9: 564. PMID 30483160 DOI: 10.3389/Fpsyt.2018.00564 |
0.609 |
|
| 2018 |
Napoli E, Schneider A, Hagerman R, Song G, Wong S, Tassone F, Giulivi C. Impact of Premutation on Neurobehavior and Bioenergetics in Young Monozygotic Twins. Frontiers in Genetics. 9: 338. PMID 30210529 DOI: 10.3389/Fgene.2018.00338 |
0.541 |
|
| 2018 |
Napoli E, Schneider A, Wang JY, Trivedi A, Carrillo NR, Tassone F, Rogawski M, Hagerman RJ, Giulivi C. Allopregnanolone Treatment Improves Plasma Metabolomic Profile Associated with GABA Metabolism in Fragile X-Associated Tremor/Ataxia Syndrome: a Pilot Study. Molecular Neurobiology. PMID 30187385 DOI: 10.1007/S12035-018-1330-3 |
0.576 |
|
| 2018 |
Al Olaby RR, Tang HT, Durbin-Johnson B, Schneider A, Hessl D, Rivera SM, Tassone F. Assessment of Molecular Measures in Non-FXTAS Male Premutation Carriers. Frontiers in Genetics. 9: 302. PMID 30186307 DOI: 10.3389/Fgene.2018.00302 |
0.725 |
|
| 2018 |
Benyakorn S, Calub CA, Riley SJ, Schneider A, Iosif AM, Solomon M, Hessl D, Schweitzer JB. Computerized Cognitive Training in Children With Autism and Intellectual Disabilities: Feasibility and Satisfaction Study. Jmir Mental Health. 5: e40. PMID 29802090 DOI: 10.2196/Mental.9564 |
0.613 |
|
| 2017 |
Jiraanont P, Sweha SR, AlOlaby RR, Silva M, Tang HT, Durbin-Johnson B, Schneider A, Espinal GM, Hagerman PJ, Rivera SM, Hessl D, Hagerman RJ, Chutabhakdikul N, Tassone F. Clinical and molecular correlates in fragile X premutation females. Eneurologicalsci. 7: 49-56. PMID 28971146 DOI: 10.1016/J.Ensci.2017.04.003 |
0.773 |
|
| 2017 |
Ligsay A, Van Dijck A, Nguyen DV, Lozano R, Chen Y, Bickel ES, Hessl D, Schneider A, Angkustsiri K, Tassone F, Ceulemans B, Kooy RF, Hagerman RJ. A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome. Journal of Neurodevelopmental Disorders. 9: 26. PMID 28764646 DOI: 10.1186/S11689-017-9207-8 |
0.711 |
|
| 2017 |
Wang JY, Trivedi AM, Carrillo NR, Yang J, Schneider A, Giulivi C, Adams P, Tassone F, Kim K, Rivera SM, Lubarr N, Wu CY, Irwin RW, Brinton RD, Olichney JM, et al. Open-Label Allopregnanolone Treatment of Men with Fragile X-Associated Tremor/Ataxia Syndrome. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 28707277 DOI: 10.1007/S13311-017-0555-6 |
0.641 |
|
| 2016 |
Gossett A, Sansone S, Schneider A, Johnston C, Hagerman R, Tassone F, Rivera SM, Seritan AL, Hessl D. Psychiatric disorders among women with the fragile X premutation without children affected by fragile X syndrome. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. PMID 27615674 DOI: 10.1002/Ajmg.B.32496 |
0.778 |
|
| 2016 |
Hessl D, Sansone SM, Berry-Kravis E, Riley K, Widaman KF, Abbeduto L, Schneider A, Coleman J, Oaklander D, Rhodes KC, Gershon RC. The NIH Toolbox Cognitive Battery for intellectual disabilities: three preliminary studies and future directions. Journal of Neurodevelopmental Disorders. 8: 35. PMID 27602170 DOI: 10.1186/S11689-016-9167-4 |
0.658 |
|
| 2016 |
Greiss Hess L, Fitzpatrick SE, Nguyen DV, Chen Y, Gaul KN, Schneider A, Lemons Chitwood K, Eldeeb MA, Polussa J, Hessl D, Rivera S, Hagerman RJ. A Randomized, Double-Blind, Placebo-Controlled Trial of Low-Dose Sertraline in Young Children With Fragile X Syndrome. Journal of Developmental and Behavioral Pediatrics : Jdbp. PMID 27560971 DOI: 10.1097/Dbp.0000000000000334 |
0.772 |
|
| 2016 |
Schneider A, Johnston C, Tassone F, Sansone S, Hagerman RJ, Ferrer E, Rivera SM, Hessl D. Broad autism spectrum and obsessive-compulsive symptoms in adults with the fragile X premutation. The Clinical Neuropsychologist. 1-15. PMID 27355445 DOI: 10.1080/13854046.2016.1189536 |
0.778 |
|
| 2016 |
Napoli E, Song G, Schneider A, Hagerman R, Eldeeb MA, Azarang A, Tassone F, Giulivi C. Warburg effect linked to cognitive-executive deficits in FMR1 premutation. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 27335370 DOI: 10.1096/Fj.201600315R |
0.606 |
|
| 2016 |
Lozano R, Saito N, Reed D, Eldeeb M, Schneider A, Hessl D, Tassone F, Beckett L, Hagerman R. Aging in Fragile X Premutation Carriers. Cerebellum (London, England). PMID 27334385 DOI: 10.1007/S12311-016-0805-X |
0.684 |
|
| 2015 |
Martínez-Cerdeño V, Lechpammer M, Lott A, Schneider A, Hagerman R. Fragile X-Associated Tremor/Ataxia Syndrome in a Man in His 30s. Jama Neurology. 72: 1070-3. PMID 26368352 DOI: 10.1001/Jamaneurol.2015.1138 |
0.63 |
|
| 2015 |
Winarni TI, Schneider A, Ghaziuddin N, Seritan A, Hagerman RJ. Psychosis and catatonia in fragile X: Case report and literature review. Intractable & Rare Diseases Research. 4: 139-46. PMID 26361565 DOI: 10.5582/Irdr.2015.01028 |
0.592 |
|
| 2015 |
Basuta K, Schneider A, Gane L, Polussa J, Woodruff B, Pretto D, Hagerman R, Tassone F. High functioning male with fragile X syndrome and fragile x-associated tremor/ataxia syndrome. American Journal of Medical Genetics. Part A. PMID 25920745 DOI: 10.1002/Ajmg.A.37125 |
0.658 |
|
| 2015 |
Muzar Z, Lozano R, Schneider A, Adams PE, Faradz SM, Tassone F, Hagerman RJ. Methadone use in a male with the FMRI premutation and FXTAS. American Journal of Medical Genetics. Part A. 167: 1354-9. PMID 25900641 DOI: 10.1002/Ajmg.A.37030 |
0.564 |
|
| 2014 |
Au J, Berkowitz-Sutherland L, Schneider A, Schweitzer JB, Hessl D, Hagerman R. A feasibility trial of Cogmed working memory training in fragile X syndrome. Journal of Pediatric Genetics. 3: 147-56. PMID 27625871 DOI: 10.3233/Pge-14098 |
0.689 |
|
| 2014 |
Sansone SM, Schneider A, Bickel E, Berry-Kravis E, Prescott C, Hessl D. Improving IQ measurement in intellectual disabilities using true deviation from population norms. Journal of Neurodevelopmental Disorders. 6: 16. PMID 26491488 DOI: 10.1186/1866-1955-6-16 |
0.585 |
|
| 2014 |
Díez-Juan M, Schneider A, Phillips T, Lozano R, Tassone F, Solomon M, Hagerman RJ. Parent-delivered touchscreen intervention for children with fragile X syndrome. Intractable & Rare Diseases Research. 3: 166-77. PMID 25606367 DOI: 10.5582/Irdr.2014.01026 |
0.549 |
|
| 2014 |
Muzar Z, Adams PE, Schneider A, Hagerman RJ, Lozano R. Addictive substances may induce a rapid neurological deterioration in fragile X-associated tremor ataxia syndrome: A report of two cases. Intractable & Rare Diseases Research. 3: 162-5. PMID 25606366 DOI: 10.5582/Irdr.2014.01023 |
0.562 |
|
| 2014 |
Hagerman R, Lozano R, Schneider A. Translational research guided by animal studies in Fragile X Disorders. Intractable & Rare Diseases Research. 3: 100. PMID 25606359 DOI: 10.5582/Irdr.2014.01033 |
0.602 |
|
| 2014 |
Polussa J, Schneider A, Hagerman R. Molecular Advances Leading to Treatment Implications for Fragile X Premutation Carriers. Brain Disorders & Therapy. 3. PMID 25436181 DOI: 10.4172/2168-975X.1000119 |
0.604 |
|
| 2014 |
Grigsby J, Cornish K, Hocking D, Kraan C, Olichney JM, Rivera SM, Schneider A, Sherman S, Wang JY, Yang JC. The cognitive neuropsychological phenotype of carriers of the FMR1 premutation. Journal of Neurodevelopmental Disorders. 6: 28. PMID 25136377 DOI: 10.1186/1866-1955-6-28 |
0.753 |
|
| 2014 |
Yang JC, Chi L, Teichholtz S, Schneider A, Nanakul R, Nowacki R, Seritan A, Reed B, DeCarli C, Iragui VJ, Kutas M, Hagerman PJ, Hagerman RJ, Olichney JM. ERP abnormalities elicited by word repetition in fragile X-associated tremor/ataxia syndrome (FXTAS) and amnestic MCI. Neuropsychologia. 63: 34-42. PMID 25111034 DOI: 10.1016/J.Neuropsychologia.2014.08.001 |
0.759 |
|
| 2014 |
Yang JC, Niu YQ, Simon C, Seritan AL, Chen L, Schneider A, Moghaddam ST, Hagerman PJ, Hagerman RJ, Olichney JM. Memantine effects on verbal memory in fragile X-associated tremor/ataxia syndrome (FXTAS): a double-blind brain potential study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 2760-8. PMID 24871547 DOI: 10.1038/Npp.2014.122 |
0.723 |
|
| 2014 |
Seritan AL, Nguyen DV, Mu Y, Tassone F, Bourgeois JA, Schneider A, Cogswell JB, Cook KR, Leehey MA, Grigsby J, Olichney JM, Adams PE, Legg W, Zhang L, Hagerman PJ, et al. Memantine for fragile X-associated tremor/ataxia syndrome: a randomized, double-blind, placebo-controlled trial. The Journal of Clinical Psychiatry. 75: 264-71. PMID 24345444 DOI: 10.4088/Jcp.13M08546 |
0.727 |
|
| 2014 |
Yang JC, Simon C, Schneider A, Seritan AL, Hamilton L, Hagerman PJ, Hagerman RJ, Olichney JM. Abnormal semantic processing in females with fragile X-associated tremor/ataxia syndrome. Genes, Brain, and Behavior. 13: 152-62. PMID 24299169 DOI: 10.1111/Gbb.12114 |
0.587 |
|
| 2014 |
Zhang L, Sukharev D, Schneider A, Olichney JM, Seritan A, Hagerman RJ. Case report: Dystonia in a fragile X carrier. Movement Disorders : Official Journal of the Movement Disorder Society. 29: E4-5. PMID 21469199 DOI: 10.1002/Mds.23600 |
0.773 |
|
| 2013 |
Seritan AL, Bourgeois JA, Schneider A, Mu Y, Hagerman RJ, Nguyen DV. Ages of Onset of Mood and Anxiety Disorders in Fragile X Premutation Carriers. Current Psychiatry Reviews. 9: 65-71. PMID 25844075 DOI: 10.2174/157340013805289662 |
0.521 |
|
| 2013 |
Schneider A, Leigh MJ, Adams P, Nanakul R, Chechi T, Olichney J, Hagerman R, Hessl D. Electrocortical changes associated with minocycline treatment in fragile X syndrome. Journal of Psychopharmacology (Oxford, England). 27: 956-63. PMID 23981511 DOI: 10.1177/0269881113494105 |
0.774 |
|
| 2013 |
Schneider A, Ligsay A, Hagerman RJ. Fragile X syndrome: an aging perspective. Developmental Disabilities Research Reviews. 18: 68-74. PMID 23949830 DOI: 10.1002/Ddrr.1129 |
0.614 |
|
| 2013 |
Schneider A, Seritan A, Tassone F, Rivera SM, Hagerman R, Hessl D. Psychiatric features in high-functioning adult brothers with fragile x spectrum disorders. The Primary Care Companion For Cns Disorders. 15. PMID 23930232 DOI: 10.4088/Pcc.12L01492 |
0.791 |
|
| 2013 |
Basuta K, Lozano R, Schneider A, Yrigollen CM, Hessl D, Hagerman RJ, Tassone F. A family with two female siblings with compound heterozygous FMR1 premutation alleles. Clinical Genetics. 85: 458-63. PMID 23786467 DOI: 10.1111/Cge.12218 |
0.693 |
|
| 2013 |
Wang JY, Hessl D, Schneider A, Tassone F, Hagerman RJ, Rivera SM. Fragile X-associated tremor/ataxia syndrome: influence of the FMR1 gene on motor fiber tracts in males with normal and premutation alleles. Jama Neurology. 70: 1022-9. PMID 23753897 DOI: 10.1001/Jamaneurol.2013.2934 |
0.762 |
|
| 2013 |
Yang JC, Simon C, Niu YQ, Bogost M, Schneider A, Tassone F, Seritan A, Grigsby J, Hagerman PJ, Hagerman RJ, Olichney JM. Phenotypes of hypofrontality in older female fragile X premutation carriers. Annals of Neurology. 74: 275-83. PMID 23686745 DOI: 10.1002/Ana.23933 |
0.755 |
|
| 2013 |
Leigh MJ, Nguyen DV, Mu Y, Winarni TI, Schneider A, Chechi T, Polussa J, Doucet P, Tassone F, Rivera SM, Hessl D, Hagerman RJ. A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile x syndrome. Journal of Developmental and Behavioral Pediatrics : Jdbp. 34: 147-55. PMID 23572165 DOI: 10.1097/Dbp.0B013E318287Cd17 |
0.764 |
|
| 2013 |
Wang JY, Hessl D, Iwahashi C, Cheung K, Schneider A, Hagerman RJ, Hagerman PJ, Rivera SM. Influence of the fragile X mental retardation (FMR1) gene on the brain and working memory in men with normal FMR1 alleles. Neuroimage. 65: 288-98. PMID 23063447 DOI: 10.1016/J.Neuroimage.2012.09.075 |
0.734 |
|
| 2013 |
Yang JC, Chan SH, Khan S, Schneider A, Nanakul R, Teichholtz S, Niu YQ, Seritan A, Tassone F, Grigsby J, Hagerman PJ, Hagerman RJ, Olichney JM. Neural substrates of executive dysfunction in fragile X-associated tremor/ataxia syndrome (FXTAS): a brain potential study. Cerebral Cortex (New York, N.Y. : 1991). 23: 2657-66. PMID 22918986 DOI: 10.1093/Cercor/Bhs251 |
0.733 |
|
| 2012 |
Wang JM, Koldewyn K, Hashimoto R, Schneider A, Le L, Tassone F, Cheung K, Hagerman P, Hessl D, Rivera SM. Male carriers of the FMR1 premutation show altered hippocampal-prefrontal function during memory encoding. Frontiers in Human Neuroscience. 6: 297. PMID 23115550 DOI: 10.3389/Fnhum.2012.00297 |
0.706 |
|
| 2012 |
Winarni TI, Schneider A, Borodyanskara M, Hagerman RJ. Early intervention combined with targeted treatment promotes cognitive and behavioral improvements in young children with fragile x syndrome. Case Reports in Genetics. 2012: 280813. PMID 23074686 DOI: 10.1155/2012/280813 |
0.585 |
|
| 2012 |
Knox A, Schneider A, Abucayan F, Hervey C, Tran C, Hessl D, Berry-Kravis E. Feasibility, reliability, and clinical validity of the Test of Attentional Performance for Children (KiTAP) in Fragile X syndrome (FXS). Journal of Neurodevelopmental Disorders. 4: 2. PMID 22958782 DOI: 10.1186/1866-1955-4-2 |
0.655 |
|
| 2012 |
Sorensen PL, Basuta K, Mendoza-Morales G, Gane LW, Schneider A, Hagerman R, Tassone F. A fragile X sibship from a consanguineous family with a compound heterozygous female and partially methylated full mutation male. American Journal of Medical Genetics. Part A. 158: 1221-4. PMID 22488807 DOI: 10.1002/Ajmg.A.35293 |
0.507 |
|
| 2012 |
Chonchaiya W, Au J, Schneider A, Hessl D, Harris SW, Laird M, Mu Y, Tassone F, Nguyen DV, Hagerman RJ. Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder. Human Genetics. 131: 581-9. PMID 22001913 DOI: 10.1007/S00439-011-1106-6 |
0.67 |
|
| 2012 |
Schneider A, Ballinger E, Chavez A, Tassone F, Hagerman RJ, Hessl D. Prepulse inhibition in patients with fragile X-associated tremor ataxia syndrome. Neurobiology of Aging. 33: 1045-53. PMID 20961665 DOI: 10.1016/J.Neurobiolaging.2010.09.002 |
0.748 |
|
| 2011 |
Hessl D, Wang JM, Schneider A, Koldewyn K, Le L, Iwahashi C, Cheung K, Tassone F, Hagerman PJ, Rivera SM. Decreased fragile X mental retardation protein expression underlies amygdala dysfunction in carriers of the fragile X premutation. Biological Psychiatry. 70: 859-65. PMID 21783174 DOI: 10.1016/J.Biopsych.2011.05.033 |
0.768 |
|
| 2011 |
Bourgeois JA, Seritan AL, Casillas EM, Hessl D, Schneider A, Yang Y, Kaur I, Cogswell JB, Nguyen DV, Hagerman RJ. Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers. The Journal of Clinical Psychiatry. 72: 175-82. PMID 20816038 DOI: 10.4088/Jcp.09M05407Blu |
0.694 |
|
| 2011 |
Yuhas J, Cordeiro L, Tassone F, Ballinger E, Schneider A, Long JM, Ornitz EM, Hessl D. Brief report: Sensorimotor gating in idiopathic autism and autism associated with fragile X syndrome. Journal of Autism and Developmental Disorders. 41: 248-53. PMID 20521090 DOI: 10.1007/S10803-010-1040-9 |
0.621 |
|
| 2011 |
Hagerman RJ, Turk J, Schneider A, Hagerman PJ. Fragile X syndrome: Medical and genetic aspects The Sage Handbook of Developmental Disorders. 43-56. DOI: 10.4135/9781446201107.n4 |
0.493 |
|
| 2010 |
Ortigas MC, Bourgeois JA, Schneider A, Olichney J, Nguyen DV, Cogswell JB, Hall DA, Hagerman RJ. Improving fragile X-associated tremor/ataxia syndrome symptoms with memantine and venlafaxine. Journal of Clinical Psychopharmacology. 30: 642-4. PMID 20841969 DOI: 10.1097/Jcp.0B013E3181F1D10A |
0.77 |
|
| 2010 |
Chonchaiya W, Tassone F, Ashwood P, Hessl D, Schneider A, Campos L, Nguyen DV, Hagerman RJ. Autoimmune disease in mothers with the FMR1 premutation is associated with seizures in their children with fragile X syndrome. Human Genetics. 128: 539-48. PMID 20809278 DOI: 10.1007/S00439-010-0882-8 |
0.673 |
|
| 2010 |
Utari A, Chonchaiya W, Rivera SM, Schneider A, Hagerman RJ, Faradz SM, Ethell IM, Nguyen DV. Side effects of minocycline treatment in patients with fragile X syndrome and exploration of outcome measures. American Journal On Intellectual and Developmental Disabilities. 115: 433-43. PMID 20687826 DOI: 10.1352/1944-7558-115.5.433 |
0.721 |
|
| 2010 |
Olichney JM, Chan S, Wong LM, Schneider A, Seritan A, Niese A, Yang JC, Laird K, Teichholtz S, Khan S, Tassone F, Hagerman R. Abnormal N400 word repetition effects in fragile X-associated tremor/ataxia syndrome. Brain : a Journal of Neurology. 133: 1438-50. PMID 20410144 DOI: 10.1093/Brain/Awq077 |
0.759 |
|
| 2010 |
Schneider A, Hagerman RJ, Hessl D. Fragile X syndrome -- from genes to cognition. Developmental Disabilities Research Reviews. 15: 333-42. PMID 20014363 DOI: 10.1002/Ddrr.80 |
0.451 |
|
| 2010 |
Chonchaiya W, Au J, Schneider A, Harris SW, Cordeiro L, Hessl DR, Laird M, Utari A, Hagerman RJ. Increased Prevalence of Seizures, ASD, and ADHD in Boys with the Fragile X Premutation Journal of Developmental & Behavioral Pediatrics. 31: E1-E2. DOI: 10.1097/01.Dbp.0000390251.03412.6C |
0.678 |
|
| 2009 |
Chonchaiya W, Schneider A, Hagerman RJ. Fragile X: a family of disorders. Advances in Pediatrics. 56: 165-86. PMID 19968948 DOI: 10.1016/J.Yapd.2009.08.008 |
0.572 |
|
| 2009 |
Hessl D, Nguyen DV, Green C, Chavez A, Tassone F, Hagerman RJ, Senturk D, Schneider A, Lightbody A, Reiss AL, Hall S. A solution to limitations of cognitive testing in children with intellectual disabilities: the case of fragile X syndrome. Journal of Neurodevelopmental Disorders. 1: 33-45. PMID 19865612 DOI: 10.1007/S11689-008-9001-8 |
0.693 |
|
| 2009 |
Seritan AL, Schneider A, Olichney JM, Leehey MA, Akins RS, Hagerman RJ. Conversion disorder in women with the FMR1 premutation. American Journal of Medical Genetics. Part A. 149: 2501-6. PMID 19842197 DOI: 10.1002/Ajmg.A.33054 |
0.748 |
|
| 2009 |
Berry-Kravis E, Hessl D, Coffey S, Hervey C, Schneider A, Yuhas J, Hutchison J, Snape M, Tranfaglia M, Nguyen DV, Hagerman R. A pilot open label, single dose trial of fenobam in adults with fragile X syndrome Journal of Medical Genetics. 46: 266-271. PMID 19126569 DOI: 10.1136/Jmg.2008.063701 |
0.677 |
|
| 2008 |
Hagerman R, Berry-Kravis E, Hessl D, Coffey S, Schneider A, Nguyen D, Hervey C, Hutchison J, Snape M. Trial of fenobam, an mGluR5 antagonist, in adults with Fragile X Syndrome Journal of Intellectual Disability Research. 52: 814-814. DOI: 10.1111/J.1365-2788.2008.01119_9.X |
0.691 |
|
| Show low-probability matches. |